Package 70377-010-11

{"route": ["ORAL"], "spl_id": "4e63b36e-3d75-b3b0-42b6-f2f3c1ddf4d0", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "unii": ["9HW64Q8G6G"], "rxcui": ["845507", "845515", "998189", "1119400"], "spl_set_id": ["5fb55800-f322-6bb6-9dde-622925ef28bd"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Biocon Pharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (70377-010-11)", "package_ndc": "70377-010-11", "marketing_start_date": "20230608"}, {"sample": false, "description": "4 BLISTER PACK in 1 CARTON (70377-010-22)  / 7 TABLET in 1 BLISTER PACK", "package_ndc": "70377-010-22", "marketing_start_date": "20211001"}, {"sample": false, "description": "4 BLISTER PACK in 1 CARTON (70377-010-23)  / 7 TABLET in 1 BLISTER PACK", "package_ndc": "70377-010-23", "marketing_start_date": "20240517"}], "brand_name": "EVEROLIMUS", "product_id": "70377-010_4e63b36e-3d75-b3b0-42b6-f2f3c1ddf4d0", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "70377-010", "generic_name": "everolimus", "labeler_name": "Biocon Pharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EVEROLIMUS", "active_ingredients": [{"name": "EVEROLIMUS", "strength": "2.5 mg/1"}], "application_number": "ANDA214182", "marketing_category": "ANDA", "marketing_start_date": "20211001", "listing_expiration_date": "20261231"}